Otonomy Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Back to Jobs

Conference call and webcast today at 4:30 p.m. EST Conference call will include review of OTO-413 program selected as “Hot Topic” at Society for Neuroscience Annual Meeting SAN DIEGO , Nov. 05, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the

Apply Now